Literature DB >> 3008459

Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses.

H F Clark, P A Offit, K T Dolan, A Tezza, K Gogalin, E M Twist, S A Plotkin.   

Abstract

Small groups of adult volunteers, in sequence, were inoculated orally with inactivated purified bovine rotavirus of strain NCDV, with live NCDV purified or unpurified and with two different NCDV X human rotavirus reassortant viruses. One of five volunteers given 200 micrograms of ultravioletinactivated NCDV developed a virus-neutralizing (VN) and a binding antibody response detected by enzyme-linked immunosorbent assay (ELISA). Four of 10 volunteers given from 1 X 10(6) to 1 X 10(8) p.f.u. of live NCDV developed VN antibody, but nine of 10 responded when ELISA, HAI and radioimmuno-precipitation tests for serum antibody were also considered. Two different NCDV X human serotype 1 Wa strain virus reassortants, each containing Wa gene segment 9 and the serotype 1 neutralization phenotype, were administered orally in doses up to 10(6) p.f.u. The reassortants were relatively ineffective in eliciting a serum antibody response at the dosage level employed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008459     DOI: 10.1016/0264-410x(86)90094-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.

Authors:  R L Ward; D R Knowlton; H B Greenberg; G M Schiff; D I Bernstein
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.

Authors:  Y Hoshino; L J Saif; M M Sereno; R M Chanock; A Z Kapikian
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Rotavirus isolate WI61 representing a presumptive new human serotype.

Authors:  H F Clark; Y Hoshino; L M Bell; J Groff; G Hess; P Bachman; P A Offit
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

4.  Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus.

Authors:  R L Ward; D R Knowlton; G M Schiff; Y Hoshino; H B Greenberg
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro.

Authors:  Y Hoshino; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Serologic and mucosal immune response to rotavirus infection in the rabbit model.

Authors:  M E Conner; M A Gilger; M K Estes; D Y Graham
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.